These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38830578)

  • 1. A Fast, Affordable, and Minimally Invasive Diagnostic Test for Cancer of Unknown Primary Using DNA Methylation Profiling.
    De Wilde J; Van Paemel R; De Koker A; Roelandt S; Van de Velde S; Callewaert N; Van Dorpe J; Creytens D; De Wilde B; De Preter K
    Lab Invest; 2024 Aug; 104(8):102091. PubMed ID: 38830578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
    Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K
    Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.
    Zhang S; He S; Zhu X; Wang Y; Xie Q; Song X; Xu C; Wang W; Xing L; Xia C; Wang Q; Li W; Zhang X; Yu J; Ma S; Shi J; Gu H
    Nat Commun; 2023 Sep; 14(1):5686. PubMed ID: 37709764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples.
    Mattesen TB; Andersen CL; Bramsen JB
    Clin Epigenetics; 2021 Jan; 13(1):20. PubMed ID: 33509261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisulfite Conversion of DNA from Tissues, Cell Lines, Buffy Coat, FFPE Tissues, Microdissected Cells, Swabs, Sputum, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.
    Jung M; Uhl B; Kristiansen G; Dietrich D
    Methods Mol Biol; 2017; 1589():139-159. PubMed ID: 26138988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
    Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
    Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.
    Wen X; Jeong S; Kim Y; Bae JM; Cho NY; Kim JH; Kang GH
    Clin Epigenetics; 2017; 9():1. PubMed ID: 28149329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary.
    Conway AM; Pearce SP; Clipson A; Hill SM; Chemi F; Slane-Tan D; Ferdous S; Hossain ASMM; Kamieniecka K; White DJ; Mitchell C; Kerr A; Krebs MG; Brady G; Dive C; Cook N; Rothwell DG
    Nat Commun; 2024 Apr; 15(1):3292. PubMed ID: 38632274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
    Werner TV; Kock S; Weber I; Kayser G; Werner M; Lassmann S
    J Mol Diagn; 2022 Jul; 24(7):784-802. PubMed ID: 35787794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
    Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
    Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A streamlined method for analysing genome-wide DNA methylation patterns from low amounts of FFPE DNA.
    Ludgate JL; Wright J; Stockwell PA; Morison IM; Eccles MR; Chatterjee A
    BMC Med Genomics; 2017 Aug; 10(1):54. PubMed ID: 28859641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary.
    Chen K; Zhang F; Yu X; Huang Z; Gong L; Xu Y; Li H; Yu S; Fan Y
    J Transl Med; 2022 Apr; 20(1):158. PubMed ID: 35382836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.
    Olbryt M; Rajczykowski M; Bal W; Fiszer-Kierzkowska A; Cortez AJ; Mazur M; Suwiński R; Widłak W
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A methodological study of genome-wide DNA methylation analyses using matched archival formalin-fixed paraffin embedded and fresh frozen breast tumors.
    Espinal AC; Wang D; Yan L; Liu S; Tang L; Hu Q; Morrison CD; Ambrosone CB; Higgins MJ; Sucheston-Campbell LE
    Oncotarget; 2017 Feb; 8(9):14821-14829. PubMed ID: 28118602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
    Yang SR; Mooney KL; Libiran P; Jones CD; Joshi R; Lau HD; Stehr H; Berry GJ; Zehnder JL; Long SR; Kong CS; Kunder CA
    Cancer Cytopathol; 2020 Jan; 128(1):43-56. PubMed ID: 31751001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
    Ferracin M; Pedriali M; Veronese A; Zagatti B; Gafà R; Magri E; Lunardi M; Munerato G; Querzoli G; Maestri I; Ulazzi L; Nenci I; Croce CM; Lanza G; Querzoli P; Negrini M
    J Pathol; 2011 Sep; 225(1):43-53. PubMed ID: 21630269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency of the S5 DNA methylation classifier in formalin-fixed biopsies versus corresponding exfoliated cells for the detection of pre-cancerous cervical lesions.
    Reuter C; Preece M; Banwait R; Boer S; Cuzick J; Lorincz A; Nedjai B
    Cancer Med; 2021 Apr; 10(8):2668-2679. PubMed ID: 33710792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology.
    Amatori S; Persico G; Paolicelli C; Hillje R; Sahnane N; Corini F; Furlan D; Luzi L; Minucci S; Giorgio M; Pelicci PG; Fanelli M
    Clin Epigenetics; 2018 Nov; 10(1):143. PubMed ID: 30446010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.